NCT04835194 Phenotypes and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With Hypertension and Diabetes Status COMPLETED Phase N/A
NCT04788576 Distribution and Clinical Implication of CMD in Patients With HFpEF Without Significant CAD Status RECRUITING Phase N/A
NCT04766892 A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT Status COMPLETED Phase PHASE2
NCT04757584 Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF Status COMPLETED Phase PHASE4
NCT04745013 PeRsonalIzed remOtely Guided Preventive exeRcIse Therapy for a healThY Heart Status RECRUITING Phase NA
NCT04739215 Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF Status UNKNOWN Phase PHASE4
NCT04633460 Acute Effects of Exogenous Ketone Ester Administration in Heart Failure Status COMPLETED Phase PHASE2
NCT04594499 The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF Patients Status UNKNOWN Phase N/A
NCT04535726 The Relationship Between Blood Pressure and Arterial Stiffness in HFpEF Patients With Different Levels of Obesity Status COMPLETED Phase N/A
NCT04455828 Wearable Remote Monitoring of Heart Rate and Respiratory Rate for Heart Failure Status WITHDRAWN Phase N/A
NCT04434664 BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF Status COMPLETED Phase PHASE4